Mylan NV faced questions on Monday about the profit on its EpiPen emergency allergy treatment, following a report that the company makes 60 percent more on the injector than it had told Congress.
French drugmaker Sanofi and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab, seen by analysts as a potential $3 billion-a-year seller, by next March.
(Reuters Health) - The most important thing nurses provide to nursing home patients are dignity, personhood and quality of life, but training in these aspects of care is lacking, according to a U.K. study.
NEW YORK Clovis Oncology Inc's share price has doubled in the past month, fueled by positive developments for the company's experimental cancer drug and takeover speculation. But some investors also appear to be increasing bets against the stock.
Vela Diagnostics said its test for the Zika virus had received "emergency use authorization" from the U.S. Food and Drug Administration.